Search details
1.
Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study.
J Am Acad Dermatol
; 90(5): 945-952, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38340127
Results
1 -
1
de 1
1
Next >
>>